| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |